Letting the right one in: evaluating the generalisability of clinical trials

Rahul Shrimanker, Richard Beasley, Ciléin Kearns

Source: Eur Respir J, 52 (6) 1802218; 10.1183/13993003.02218-2018
Journal Issue: December

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Rahul Shrimanker, Richard Beasley, Ciléin Kearns. Letting the right one in: evaluating the generalisability of clinical trials. Eur Respir J, 52 (6) 1802218; 10.1183/13993003.02218-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
From clinical trials to real-world data: New dimensions of patient benefits
Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights
Year: 2015


Negative clinical trials in sarcoidosis: failed therapies or flawed study design?
Source: Eur Respir J 2014; 44: 1123-1126
Year: 2014


Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomised controlled trials on pulmonary rehabilitation
Source: Annual Congress 2010 - Outcomes and predictors of the sucess of pulmonary rehabilitation in chronic respiratory disease
Year: 2010

New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



Translating trials to clinical practice: results ²more real than real life itself²¹
Source: Annual Congress 2007 - Smoking cessation
Year: 2007


Large trials, new knowledge: the changing face of COPD management
Source: Eur Respir J 2015; 45: 1692-1703
Year: 2015




Randomised controlled trials and real-life studies: two answers for one question
Source: Eur Respir Rev, 27 (149) 180080; 10.1183/16000617.0080-2018
Year: 2018



Missing data in IPF trials: do not let methodological issues undermine a major therapeutic breakthrough
Source: Eur Respir J 2015; 46: 607-614
Year: 2015


Do the current endpoints in IPF clinical trials allow good regulatory decisions to be made?
Source: International Congress 2014 – Ceremony for the ERS Rare Pulmonary Disease Research Award 2014 followed by the symposium "Challenges in endpoints for rare lung diseases"
Year: 2014



The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018


Preschool asthma - have randomised controlled trials provided clarity on management?
Source: International Congress 2018 – Infectious agents and childhood asthma
Year: 2018


Minimising selection bias in cluster randomised controlled trials: Practical solutions
Source: Annual Congress 2010 - From diagnosis to disease management in primary care
Year: 2010

Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

Noninvasive strategies in COVID-19: epistemology, randomised trials, guidelines, physiology
Source: Eur Respir J, 57 (2) 2004247; 10.1183/13993003.04247-2020
Year: 2021



Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019


Clinical case discussion: How clinical trials inform antibiotic stewardship
Source: ERS webinar 2022: Clinical case discussion: How clinical trials inform antibiotic stewardship
Year: 2022


Clinical trials in idiopathic pulmonary fibrosis: a word of caution concerning choice of outcome measures
Source: Eur Respir J 2005; 26: 755-758
Year: 2005


Clinical trials design in the age of precision medicine
Source: ERS webinar 2020: Clinical trials design in the age of precision medicine
Year: 2020


Key role of patients in clinical trials
Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research
Year: 2013